Document ID: chunk:federal_register_of_legislation:F2024L01065:clause:1_37
Version: federal_register_of_legislation:F2024L01065
Segment Type: clause
Provision Reference: sch 1 cl 37
Character Range: 15488–15817

37  Schedule 1 (table)
After:
Riluzole  Oral suspension 50 mg per 10 mL, 300 mL  Oral  Teglutik  between 1 April 2024 and 30 September 2024—4 months stock by reference to usual demand

insert:
Riluzole  Tablet 50 mg  Oral  APO-Riluzole  between 1 September 2024 and 31 October 2024—0 months stock by reference to usual demand